Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Aug 28, 2012 (14 years ago)

I-C Drops

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility: The product is being recalled because the product label does not state sterile in accordance with 21 CFR Part 200.50(a)(1), Ophthalmic Preparations and Dispensers, and it is not in compliance with 21 CFR Part 349, Ophthalmic Drug Products for Over-The-Counter Use.

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

I-C Drops, Eye Cleansing Agent, 15 ml ASN/Maxam P.O. Box 1277 Hood River, OR 97031

Recalling firm
James G. Cole, Inc.
Origin
OR, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-129-2013 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other sterility / contamination recalls from 2012

All sterility / contamination recalls
Class I · High risk

Cyanocobalamin 1000 mcg/ml

Non-Sterility: Green Valley Drugs received positive sterility results from their testing lab on two lots of Methylprednisolone Preservative Free 40 mg/mL injectable suspension and one lot of Cyanocobalamin 1000 mcg/mL injection, 30 mL MDV.

Terminated Sterility / contamination Green Valley Drugs D-322-2013
Class III · Low risk

TORISEL Kit

Lack of Assurance of Sterility; potential that a low level of endotoxins may be present in the diluent vials.

Terminated Sterility / contamination Pfizer Inc. NDC 0008-1179-01 D-219-2013
Class II · Moderate risk

Nalbuphine HCl Injection

Lack of Assurance of Sterility: Complains of a loose crimp applied to the fliptop vial; and a missing stopper and flip cap were received and therefore sterility cannot be assured.

Terminated Sterility / contamination Hospira, Inc. NDC 0409-1467-01 D-096-2013